3,4-bis(hydroxymethyl)-5-methoxy-N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]benzamide;3-(dimethylamino)-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide;N-[2-[3-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]naphthalene-2-carboxamide;3,4,5-trimethoxy-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide

C96H90N16O13S2 — CID 162092943

IUPAC3,4-bis(hydroxymethyl)-5-methoxy-N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]benzamide;3-(dimethylamino)-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide;N-[2-[3-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]naphthalene-2-carboxamide;3,4,5-trimethoxy-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide
SMILESCN(C)c1cccc(C(=O)Nc2ccccc2-c2nc3ncccc3o2)c1.COc1cc(C(=O)Nc2ccccc2-c2cn3c(CN4CCNCC4)csc3n2)cc(CO)c1CO.COc1cc(C(=O)Nc2ccccc2-c2nc3ncccc3o2)cc(OC)c1OC.O=C(Nc1ccccc1-c1cn2c(CN3CC[C@@H](O)C3)csc2n1)c1ccc2ccccc2c1
InChIInChI=1S/C27H24N4O2S.C26H29N5O4S.C22H19N3O5.C21H18N4O2/c32-22-11-12-30(15-22)14-21-17-34-27-29-25(16-31(21)27)23-7-3-4-8-24(23)28-26(33)20-10-9-18-5-1-2-6-19(18)13-20;1-35-24-11-17(10-18(14-32)21(24)15-33)25(34)28-22-5-3-2-4-20(22)23-13-31-19(16-36-26(31)29-23)12-30-8-6-27-7-9-30;1-27-17-11-13(12-18(28-2)19(17)29-3)21(26)24-15-8-5-4-7-14(15)22-25-20-16(30-22)9-6-10-23-20;1-25(2)15-8-5-7-14(13-15)20(26)23-17-10-4-3-9-16(17)21-24-19-18(27-21)11-6-12-22-19/h1-10,13,16-17,22,32H,11-12,14-15H2,(H,28,33);2-5,10-11,13,16,27,32-33H,6-9,12,14-15H2,1H3,(H,28,34);4-12H,1-3H3,(H,24,26);3-13H,1-2H3,(H,23,26)/t22-;;;/m1.../s1
InChIKeyZDVZORAMXXHFHX-YJZWPAEXSA-N
MW1740.01 g/mol
LogP16.12
Rot. Bonds23

About 3,4-bis(hydroxymethyl)-5-methoxy-N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]benzamide;3-(dimethylamino)-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide;N-[2-[3-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]naphthalene-2-carboxamide;3,4,5-trimethoxy-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide

3,4-bis(hydroxymethyl)-5-methoxy-N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]benzamide;3-(dimethylamino)-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide;N-[2-[3-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]naphthalene-2-carboxamide;3,4,5-trimethoxy-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide (PubChem CID 162092943) has the molecular formula C96H90N16O13S2 and a molecular weight of 1740.01 g/mol. Its IUPAC name is 3,4-bis(hydroxymethyl)-5-methoxy-N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]benzamide;3-(dimethylamino)-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide;N-[2-[3-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]naphthalene-2-carboxamide;3,4,5-trimethoxy-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide.

Molecular Properties

Compound Name3,4-bis(hydroxymethyl)-5-methoxy-N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]benzamide;3-(dimethylamino)-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide;N-[2-[3-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]naphthalene-2-carboxamide;3,4,5-trimethoxy-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide
PubChem CID162092943
Molecular FormulaC96H90N16O13S2
Molecular Weight1740.01 g/mol
Exact Mass1738.63
IUPAC Name3,4-bis(hydroxymethyl)-5-methoxy-N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]benzamide;3-(dimethylamino)-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide;N-[2-[3-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]naphthalene-2-carboxamide;3,4,5-trimethoxy-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide
SMILESCN(C)c1cccc(C(=O)Nc2ccccc2-c2nc3ncccc3o2)c1.COc1cc(C(=O)Nc2ccccc2-c2cn3c(CN4CCNCC4)csc3n2)cc(CO)c1CO.COc1cc(C(=O)Nc2ccccc2-c2nc3ncccc3o2)cc(OC)c1OC.O=C(Nc1ccccc1-c1cn2c(CN3CC[C@@H](O)C3)csc2n1)c1ccc2ccccc2c1
InChIInChI=1S/C27H24N4O2S.C26H29N5O4S.C22H19N3O5.C21H18N4O2/c32-22-11-12-30(15-22)14-21-17-34-27-29-25(16-31(21)27)23-7-3-4-8-24(23)28-26(33)20-10-9-18-5-1-2-6-19(18)13-20;1-35-24-11-17(10-18(14-32)21(24)15-33)25(34)28-22-5-3-2-4-20(22)23-13-31-19(16-36-26(31)29-23)12-30-8-6-27-7-9-30;1-27-17-11-13(12-18(28-2)19(17)29-3)21(26)24-15-8-5-4-7-14(15)22-25-20-16(30-22)9-6-10-23-20;1-25(2)15-8-5-7-14(13-15)20(26)23-17-10-4-3-9-16(17)21-24-19-18(27-21)11-6-12-22-19/h1-10,13,16-17,22,32H,11-12,14-15H2,(H,28,33);2-5,10-11,13,16,27,32-33H,6-9,12,14-15H2,1H3,(H,28,34);4-12H,1-3H3,(H,24,26);3-13H,1-2H3,(H,23,26)/t22-;;;/m1.../s1
InChIKeyZDVZORAMXXHFHX-YJZWPAEXSA-N
XLogP16.12
TPSA348.20 Ų
H-Bond Donors8
H-Bond Acceptors27
Rotatable Bonds23
Heavy Atoms127
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001740.01
LogP ≤ 516.12
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1027

Analyze 3,4-bis(hydroxymethyl)-5-methoxy-N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]benzamide;3-(dimethylamino)-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide;N-[2-[3-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]naphthalene-2-carboxamide;3,4,5-trimethoxy-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3,4-bis(hydroxymethyl)-5-methoxy-N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]benzamide;3-(dimethylamino)-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide;N-[2-[3-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]naphthalene-2-carboxamide;3,4,5-trimethoxy-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide?
The IUPAC name of 3,4-bis(hydroxymethyl)-5-methoxy-N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]benzamide;3-(dimethylamino)-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide;N-[2-[3-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]naphthalene-2-carboxamide;3,4,5-trimethoxy-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide (CID 162092943) is 3,4-bis(hydroxymethyl)-5-methoxy-N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]benzamide;3-(dimethylamino)-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide;N-[2-[3-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]naphthalene-2-carboxamide;3,4,5-trimethoxy-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide.
What is the SMILES notation for 3,4-bis(hydroxymethyl)-5-methoxy-N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]benzamide;3-(dimethylamino)-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide;N-[2-[3-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]naphthalene-2-carboxamide;3,4,5-trimethoxy-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide?
The canonical SMILES for 3,4-bis(hydroxymethyl)-5-methoxy-N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]benzamide;3-(dimethylamino)-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide;N-[2-[3-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]naphthalene-2-carboxamide;3,4,5-trimethoxy-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide is CN(C)c1cccc(C(=O)Nc2ccccc2-c2nc3ncccc3o2)c1.COc1cc(C(=O)Nc2ccccc2-c2cn3c(CN4CCNCC4)csc3n2)cc(CO)c1CO.COc1cc(C(=O)Nc2ccccc2-c2nc3ncccc3o2)cc(OC)c1OC.O=C(Nc1ccccc1-c1cn2c(CN3CC[C@@H](O)C3)csc2n1)c1ccc2ccccc2c1.
What is the InChIKey of 3,4-bis(hydroxymethyl)-5-methoxy-N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]benzamide;3-(dimethylamino)-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide;N-[2-[3-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]naphthalene-2-carboxamide;3,4,5-trimethoxy-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide?
The InChIKey is ZDVZORAMXXHFHX-YJZWPAEXSA-N. The full InChI is InChI=1S/C27H24N4O2S.C26H29N5O4S.C22H19N3O5.C21H18N4O2/c32-22-11-12-30(15-22)14-21-17-34-27-29-25(16-31(21)27)23-7-3-4-8-24(23)28-26(33)20-10-9-18-5-1-2-6-19(18)13-20;1-35-24-11-17(10-18(14-32)21(24)15-33)25(34)28-22-5-3-2-4-20(22)23-13-31-19(16-36-26(31)29-23)12-30-8-6-27-7-9-30;1-27-17-11-13(12-18(28-2)19(17)29-3)21(26)24-15-8-5-4-7-14(15)22-25-20-16(30-22)9-6-10-23-20;1-25(2)15-8-5-7-14(13-15)20(26)23-17-10-4-3-9-16(17)21-24-19-18(27-21)11-6-12-22-19/h1-10,13,16-17,22,32H,11-12,14-15H2,(H,28,33);2-5,10-11,13,16,27,32-33H,6-9,12,14-15H2,1H3,(H,28,34);4-12H,1-3H3,(H,24,26);3-13H,1-2H3,(H,23,26)/t22-;;;/m1.../s1.
What are the key properties of 3,4-bis(hydroxymethyl)-5-methoxy-N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]benzamide;3-(dimethylamino)-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide;N-[2-[3-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]naphthalene-2-carboxamide;3,4,5-trimethoxy-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide?
3,4-bis(hydroxymethyl)-5-methoxy-N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]benzamide;3-(dimethylamino)-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide;N-[2-[3-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]naphthalene-2-carboxamide;3,4,5-trimethoxy-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide has a molecular weight of 1740.01 g/mol, XLogP of 16.12, 23 rotatable bonds, 8 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 3,4-bis(hydroxymethyl)-5-methoxy-N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]benzamide;3-(dimethylamino)-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide;N-[2-[3-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]naphthalene-2-carboxamide;3,4,5-trimethoxy-N-[2-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide is sourced from PubChem (CID 162092943), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).